Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New breathing device may help CF patients produce mucus for testing

NCT ID NCT06311292

First seen Apr 30, 2026 · Last updated Jun 23, 2026 · Updated 10 times

Summary

This small pilot study tested whether a breathing device called the Volara System could help adults with cystic fibrosis produce sputum (mucus from the lungs) for lab testing. The study included 20 people who had not been able to produce a sputum sample in the past year. Participants used the device during a clinic visit to try to loosen and collect mucus. The goal was to see if this method could provide enough sputum for a successful culture result.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UPMC Presbyterian Hospital

    Pittsburgh, Pennsylvania, 15213, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Volara System (a breathing device that delivers gentle air pulses to loosen mucus)

What this could lead to

If successful, this method could give doctors a better way to collect sputum for infection testing in people with cystic fibrosis who struggle to cough up mucus.

What could go wrong

This is a very small pilot study (20 people) with no comparison group, so results may not apply to everyone. The device may not work for all patients.

Conditions

The condition(s) this trial relates to.

cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.